Linked Life Data

17174870

Source:http://linkedlifedata.com/resource/pubmed/id/17174870

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2006-12-18
pubmed:abstractText
Heart failure (HF) in association with acute myocardial infarction is an emerging clinical problem. The benefits of aldosterone blockade have now been extended, with the selective aldosterone antagonist eplerenone demonstrating reduced mortality compared to placebo, in patients with post-myocardial infarction HF. The evidence supporting this agent will be briefly reviewed, followed by a discussion on the clinical implications of aldosterone antagonists in this clinical setting.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1553-8389
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
234-6
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:articleTitle
Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure.
pubmed:affiliation
Department of Cardiology, Royal Melbourne Hospital, and Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia. andrew.ajani@mh.org.au
pubmed:publicationType
Journal Article, Review